Biofrontera AG - ADR

NASDAQ:BFRA  
5.83
-0.61 (-9.47%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)165.33M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8 Million
Adjusted EPS-$0.17
See more estimates
10-Day MA$5.63
50-Day MA$5.70
200-Day MA$7.72
See more pivots

Biofrontera AG - ADR Stock, NASDAQ:BFRA

Hemmelrather Weg 201, Leverkusen, Nordrhein-Westfalen 51377
Germany
Phone: +49.214.87.63.2.0
Number of Employees: 149

Description

Biofrontera AG engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann L??bbert in 1997 and is headquartered in Leverkusen, Germany.